INHIBITION OF HUMAN DNA POLYMERASE-ALPHA BY ALPHA-1-ANTICHYMOTRYPSIN
- 1 December 1986
- journal article
- research article
- Vol. 46 (12) , 6139-6142
Abstract
.alpha.1-Antichymotrypsin (ACT), which is known as an efficient serum protease inhibitor and is detected in tumor cell nuclei, was found to inhibit the activity of DNA polymerase .alpha. purified from human stomach adenocarcinoma. The concentration of ACT required for 50% inhibition was 1.0 mg/ml and the manner of its inhibition showed the partially competitive relationship between ACT and DNA in the assay system. Furthermore the removal of ACT by anti-ACT antibody lost its antichymotryptic and anti-DNA polymerase activities in parallel. On the other hand, it did not inhibit the actiivty of human DNA polymerase .beta.. Other human serum proteins including serum albumin, .alpha.1-acid glycoprotein, .alpha.1-antitrypsin, and immunoglobulin G as well as other protease inhibitors such as leupeptin, pepstatin, phenylmethylsulfonyl fluoride, and chymostatin did not affect the activity of DNA polymerase .alpha.. Furthermore ACT heated at 60.degree. C did not inhibit DNA polymerase .alpha., although it could still bind to DNA as well as native ACT. It was therefore concluded that the inhibitory action of ACT on DNA polymerase .alpha. was a direct phenomenon unrelated to its protease inhibitory or DNA binding activities.This publication has 3 references indexed in Scilit:
- COMPARISON OF ALPHA-1-ANTITRYPSIN AND ALPHA-1-ANTICHYMOTRYPSIN IN HEPATOCELLULAR-CARCINOMA - AN IMMUNOPEROXIDASE STUDY1984
- Enhancement by α-1-antichymotrypsin of antibody response in vivoBiochemical and Biophysical Research Communications, 1981
- ASSESSMENT OF ANTICHYMOTRYPSIN IN CANCER MONITORING1978